rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2001-3-29
|
pubmed:abstractText |
A new intramuscular DNA electrotransfer method for erythropoietin (EPO) expression was evaluated in the natural mouse model of human beta-thalassemia (Hbb-thal1) in terms of its ability to reverse the anemia and improve the thalassemic features of erythrocytes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0301-472X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
295-300
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11274756-Animals,
pubmed-meshheading:11274756-Cytomegalovirus,
pubmed-meshheading:11274756-DNA, Recombinant,
pubmed-meshheading:11274756-Disease Models, Animal,
pubmed-meshheading:11274756-Electroporation,
pubmed-meshheading:11274756-Erythropoietin,
pubmed-meshheading:11274756-Female,
pubmed-meshheading:11274756-Gene Deletion,
pubmed-meshheading:11274756-Gene Therapy,
pubmed-meshheading:11274756-Genetic Vectors,
pubmed-meshheading:11274756-Globins,
pubmed-meshheading:11274756-Hematocrit,
pubmed-meshheading:11274756-Injections, Intramuscular,
pubmed-meshheading:11274756-Mice,
pubmed-meshheading:11274756-Mice, Inbred C57BL,
pubmed-meshheading:11274756-Mice, Mutant Strains,
pubmed-meshheading:11274756-Promoter Regions, Genetic,
pubmed-meshheading:11274756-Recombinant Fusion Proteins,
pubmed-meshheading:11274756-Transgenes,
pubmed-meshheading:11274756-beta-Thalassemia
|
pubmed:year |
2001
|
pubmed:articleTitle |
Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA.
|
pubmed:affiliation |
Laboratoire Expérimental de Thérapie Génique, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France. letg@chu-stlouis.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|